Moderna Inc. provided details about its plans to scale up manufacturing of its COVID-19 vaccine candidate, mRNA-1273, at a 14 April "Vaccines Day" with investors.
CEO Stéphane Bancel said its Norwood, MA, facility is ready to produce millions of doses of the vaccine, and is...






